Angiogenin 108-122

Angiogenin 108-122 is a synthetic peptide fragment derived from the C-terminal region of the human angiogenin protein, a member of the ribonuclease A superfamily known for its potent angiogenic activity. This peptide encompasses residues 108 to 122, representing a functionally significant segment implicated in the regulation of endothelial cell behavior and vascular development. As a research tool, Angiogenin 108-122 enables scientists to dissect the structure-function relationships within angiogenin and to explore mechanisms underlying neovascularization, cell migration, and extracellular matrix interactions. Its defined sequence and biochemical properties make it a valuable component in experimental systems investigating peptide-mediated signaling and protein-protein interactions in vascular biology.

Peptide structure-function studies: Angiogenin 108-122 serves as a crucial probe for investigating the specific roles of the C-terminal domain in angiogenin's biological activity. By isolating this fragment, researchers can assess how discrete peptide regions contribute to receptor binding, enzymatic activity modulation, and downstream signal transduction. Such studies are essential for elucidating the minimal sequence requirements for angiogenic function and for mapping critical residues involved in protein-ligand interactions.

Endothelial cell migration assays: Utilization of this peptide in in vitro migration assays enables detailed analysis of its impact on endothelial cell motility, a key process in angiogenesis. By applying Angiogenin 108-122 to cultured endothelial cells, investigators can quantify changes in migration rates and patterns, thereby gaining insights into the peptide's capacity to influence cytoskeletal rearrangement and cell adhesion dynamics. These findings support the broader understanding of how specific peptide motifs drive vascular remodeling.

Receptor binding analysis: The defined segment represented by Angiogenin 108-122 is instrumental in mapping binding interfaces between angiogenin and its cellular receptors. Employing this peptide in biochemical binding assays or surface plasmon resonance studies allows for the identification of interaction hotspots and affinity determinants. Such experimental approaches facilitate the rational design of peptide analogs or inhibitors that modulate angiogenin-receptor engagement, advancing both basic research and potential translational applications in vascular biology.

Peptide-based inhibitor development: The sequence of Angiogenin 108-122 provides a template for the design and synthesis of competitive inhibitors targeting angiogenin-mediated pathways. By characterizing its interaction profile and functional effects, scientists can develop modified peptides or peptidomimetics that selectively block or mimic angiogenin activity. This strategy is particularly valuable for generating research tools to dissect angiogenic signaling cascades and to validate molecular targets in neovascularization models.

Biochemical assay standardization: Owing to its well-defined structure and functional relevance, Angiogenin 108-122 is frequently employed as a positive control or reference peptide in various biochemical and cell-based assays. Its inclusion helps standardize experimental conditions, ensuring reproducibility and comparability of results across different platforms. This application is especially important in high-throughput screening protocols, where consistent assay performance is critical for identifying modulators of angiogenic activity.

1. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

2. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

4. The spatiotemporal control of signalling and trafficking of the GLP-1R

5. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury